Eagle Bay Advisors LLC Dexcom Inc Transaction History

Eagle Bay Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$84.98 - $122.67 $10,197 - $14,720	-120 Reduced 88.24%	16 $0
Q2 2022 Aug 19, 2022	BUY	$67.99 - $132.89 $9,246 - $18,073	136 New	136 $10.1 Million
Q1 2022 May 11, 2022	SELL	$94.08 - $130.2 $4,327 - $5,989	-46 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$129.87 - $162.82 $9,090 - $11,397	-70 Reduced 60.34%	46 $25,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $7,042 - $9,449	66 Added 132.0%	116 $62,000
Q2 2021 Jul 30, 2021	BUY	$80.99 - $107.93 $4,049 - $5,396	50 New	50 $22,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Eagle Bay Advisors LLC with notifications on news.